Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Symbotic Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Symbotic Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:16 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001837240-26-000043
| Line item | For the Three Months Ended / June 27, 2026 | For the Three Months Ended / June 28, 2025 | For the Nine Months Ended / June 27, 2026 | For the Nine Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Total cost of revenue | 559,928 | 480,279 | 1,583,017 | 1,324,814 |
| Gross profit | 160,910 | 111,842 | 444,286 | 303,651 |
| Operating expenses: | ||||
| Research and development expenses | 43,780 | 49,729 | 138,069 | 150,967 |
| Selling, general, and administrative expenses | 84,235 | 71,557 | 258,020 | 205,567 |
| Restructuring charges | — | 16,361 | 2,685 | 16,361 |
| Total operating expenses | 128,015 | 137,647 | 398,774 | 372,895 |
| Operating income (loss) | 32,895 | (25,805) | 45,512 | (69,244) |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Symbotic Inc.'s R&D?
- Symbotic Inc. (SYM) reported R&D of $43.78M in Q2 2026.
- How has Symbotic Inc.'s R&D changed year-over-year?
- Symbotic Inc.'s R&D decreased by 12.0% year-over-year, from $49.73M to $43.78M.
- What is the long-term trend for Symbotic Inc.'s R&D?
- Over 3 years (2022 to 2025), Symbotic Inc.'s R&D has grown at a 20.3% compound annual growth rate (CAGR), from $124.14M to $216.01M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Symbotic Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude